Distribuzione geografica
Continente #
NA - Nord America 5475
EU - Europa 432
AF - Africa 242
AS - Asia 59
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
OC - Oceania 2
Totale 6218
Nazione #
US - Stati Uniti d'America 5441
NG - Nigeria 242
FR - Francia 122
IT - Italia 84
NL - Olanda 79
GB - Regno Unito 49
BE - Belgio 43
CA - Canada 33
DE - Germania 22
IL - Israele 18
TR - Turchia 11
CN - Cina 9
JP - Giappone 7
FI - Finlandia 6
RU - Federazione Russa 6
UA - Ucraina 6
GR - Grecia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
IN - India 4
RO - Romania 4
CL - Cile 3
TW - Taiwan 3
AU - Australia 2
IR - Iran 2
KR - Corea 2
MD - Moldavia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
ID - Indonesia 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
Totale 6218
Città #
Wilmington 1497
Chandler 1488
San Mateo 555
Ann Arbor 476
Leawood 250
Lawrence 243
Princeton 243
Benin City 242
Woodbridge 133
Boardman 131
Fairfield 128
Paris 119
Amsterdam 79
San Diego 50
London 47
Seattle 44
Brussels 43
Milan 33
Norwalk 29
Toronto 28
Falls Church 24
Abbiategrasso 21
Houston 11
Kocaeli 11
Hanover 10
Des Moines 9
Monmouth Junction 8
Redmond 8
Helsinki 6
Ottawa 5
St Louis 5
Clearwater 3
Novokuznetsk 3
Redwood City 3
Andover 2
Chisinau 2
Eden Prairie 2
Ferrara 2
Henderson 2
Rome 2
Taipei 2
Alexandria 1
Beijing 1
Berlin 1
Bologna 1
Brest 1
Canton 1
Central District 1
Chicago 1
Dundee 1
Friday Harbor 1
Izhevsk 1
Jacksonville 1
Jakarta 1
Los Angeles 1
Mumbai 1
Oslo 1
Perugia 1
Phoenix 1
Queens 1
Reghin 1
Saint Paul 1
Shanghai 1
Taichung 1
Tübingen 1
Vienna 1
Xian 1
Zgierz 1
Totale 6026
Nome #
The emerging role of microRNAs in cardiovascular biology 44
Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis 43
T cell costimulation blockade blunts pressure overload-induced heart failure 41
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 40
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy 39
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 39
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 38
The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300 38
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 38
Uses and compositions comprising mirnas 38
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 37
Dr. John Ross Jr. 37
Inhalation Therapy Delivers Nanoparticle-Based Therapeutic Biomolecules To The Diseased Heart 37
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 37
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 37
Inhibition of Class I Histone Deacetylase with an Apicidine Derivative Prevents Cardiac Hypertrophy and Failure 36
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 36
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population 36
Effects of Akt on cardiac myocytes: location counts 35
MicroRNAs and cardiac pathology 35
Adenovirus-mediated gene transfer of the retinoblastoma family member p130/RB2 blocks restenosis after endothelial injury 35
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part II: HL-1 cytocompatibility and electrical characterizations 35
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 35
Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. 35
Akt1 gene transfer to the endothelium corrects impaired endothelial dependent vasorelaxation in hypertensive rats 34
Differential expression and functional role of GATA-2, NF-E2 and GATA-1 in normal adult erythropoiesis 33
Prolonged duration of myocardial ischemia in patients with coronary artery disease and impaires cardiopulmonary baroreceptor sensitivity 33
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 phospholamban 32
Human stem cells for heart failure treatment ready for prime time? 32
Chemerin processing in the myocardium: A mechanism in search of a function 32
Therapeutic use of microRNAs in myocardial diseases 32
RBP and microRNA control of endothelial cell function 32
Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis 32
Mutated p21/WAF/CIP transgene overstatement reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice 32
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure 32
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia 32
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 32
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 32
Antiphosphotyrosine recovery of an isulin-stimulated receptor phosphatase activity in FRTL5 cells 31
Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases : per aspirin ad astra 31
Stem cells for cardiac repair: state of the art 31
ATP6V0A1 polymorphism and microRNA-637: A pathogenetic role for microRNAs in essential hypertension at last? 31
MicroRNAs as Companion Biomarkers for the Diagnosis and Prognosis of Acute Coronary Syndromes 31
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents 31
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 31
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice 31
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway 31
MicroRNAs in cardiovascular disease: an introduction for clinicians 31
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 31
Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT 30
The earliest iodination site of thyroglobulin is residue number 5. The Journal of Biological Chemistry 30
Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis. 30
Circular RNAs and heart failure: new players for an old disease 30
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia 30
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes 30
An ‘advanced’-generation lentiviral vector with a short troponin-I promoter: a tool for cardiac-specific gene expression and tracking cardiomyocyte differentiation of human embryonic stem cells 30
p300/CBP modulates co-operation between MEF2A and TR/RxR 30
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 30
The role of the epigenome in heart failure 30
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 30
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 30
Circulating microRNAs and aerobic fitness : the HUNT-study 29
Immersion before dry simulated dive reduces cardiomyocyte function and increases mortality after decompression 29
Epigenetics in heart failure 29
miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases 29
The synergistic role of E1A-binding proteins and tissue-specific transcription factors in differentiation 29
Physiological myocardial hypertrophy: how and why? 29
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions 29
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy 29
DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation 29
The possible role of chromosome X variability in hypertensive familiarity. 29
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling 29
microRNAs in heart disease: putative novel therapeutic targets? 29
Stem cells for cardiomyocyte regeneration: state of the art 28
The cdc2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle 28
The long noncoding RNA landscape in cardiovascular disease: a brief update. 28
A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block. 28
The circulating level of FABP3 is an indirect biomarker of microRNA-1 28
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy 28
Critical role of HMGI(Y) proteins in adypocytic cell growth and differentiation 28
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo 28
microRNA MicroRNAs Control Gene Expression: Importance for Cardiac Development and Pathophysiology 27
MicroRNA and cardiac pathologies 27
Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure 27
Association of FOXO3A locus with extreme longevity in the Southern Italian Centenarian Study 27
Human p300 protein mediates transcription by the myogenic transactivator MyoD 27
Coordinate expression and developmental role of Id2 protein and Tal1/E2A heterodimer in erythroid progenitor differentiation 27
Enforced Tal-1 expression stimulates primitive, erythroid and megacaryocytic progenitor but blocks the granulopoietic differentiation program 27
Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary SMC and in early lesions of WHHL rabbits: protective effects of vitamin E 27
Heart failure: Targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment 27
Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls 27
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events 27
Modulatory role of Angiotensin II in the secretion of Atrial Natriuretic factor in rabbits 27
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability 27
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17 27
MicroRNAs and cardiac conduction 27
Atrial fibrillation and microRNAs 27
microRNAs in hypertrophy and heart failure 26
Epigenetics : a new mechanism of regulation of heart failure? 26
HEXIM1 : a new player in myocardial hypertrophy? 26
Totale 3136
Categoria #
all - tutte 31782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31782

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0000 00 00 0005
2020/20212667 21281911 25838 352197 54535711263
2021/20221212 312020317 2018 42202 10392246101
2022/20232492 548116348557 507402 140 0000
Totale 6376